8 29 | | | | | | | | | | | | | | | | | | 32 | 14 | 11 | | | | | | | | | | | | | | | | | | | | | | | 10 | | | | | | | | | | | | | | 2003 | 20 | | 12 | 4 | | | 30 | | | | | | | 17 | 32.9 | | | 43 61.3 | | | | | | | | | | | 123 + N | | 1 | | | 1 2 | | 3 | | N | | | | | | | | | | | | | | 10 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | A IPO | | | | | | | | | | | | | | | | | | | | 110 50 | | | | | | 12% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Q10 DHA K2 | Q10 | 50% | | Q10 | | | | 5 | 488 | | | | | | 3 5 | 9 | | | | | |